课题基金 / 基金详情

A PRELIMINARY STUDY TO EVALUATE CYSTEAMINE THERAPY IN HUMAN SUBJECTS WITH NASH

A PRELIMINARY STUDY TO EVALUATE CYSTEAMINE THERAPY IN HUMAN SUBJECTS WITH NASH
评估半胱胺治疗纳什人类受试者的初步研究
批准号:
7951009
负责人:
JOEL Edward LAVINE
金额:
$0.79万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

JOEL Edward LAVINE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To determine whether cysteamine will effectively reduce or reverse the biologic markers of steatohepatitis in human subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
XENOBIOTIC BIOTRANSFORMATION IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
CLINICAL TRIAL: TONIC - TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN
CLINICAL TRIAL: PIOGLITAZONE VS VITAMIN E VS PLACEBO FOR NONALCOHOLIC STEATOHEPA
CLINICAL TRIAL: NON-ALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK
海外基金